Blog

New approaches are required to comply with the ICH E6(R3) guideline for Good Clinical Practice (GCP), intended to drive a culture of quality. These include new ways of working, use of proportionate risk-based methods, and a culture that favors quality and rewards critical thinking.

Across the clinical research ecosystem, one truth continues to surface: time to activation matters more than ever. Delays in study start-ups don’t just slow recruitment. They shorten enrollment windows, frustrate investigators, and can ultimately determine whether a site remains competitive for future trials. Yet despite years of attention, many organizations still struggle to consistently activate studies within industry expectations. 

Whether you are a seasoned clinical research professional or a newbie to all things trial-related, getting the most out of your first time attending a major industry-focused conference like ACRP 2026 means more than having an “elevator speech” about your job role prepared and taking snapshots of the most interesting session slides. 

Whether the universe seems to be guiding you toward an “it was meant to be” career change into project management, or you have already made the switch but want to know more about what you’ve gotten yourself into, you can take a deep dive into how the project manager role fits into the clinical research enterprise during a full-day ACRP 2026 Workshop in Orlando in April.

Recruitment of clinical trial participants continues to be a major challenge, in spite of widespread investment and innovations. Recruitment delays and shortfalls increase study timelines and increase costs in an environment where everyone is trying to do more with fewer resources.